| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 07/23/2003 | EP1328266A1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 07/23/2003 | EP1140006B1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis |
| 07/23/2003 | EP0898559B1 Cytoprotective compounds |
| 07/23/2003 | CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1431898A Methods of use of penicillamines for treatment of conditions resulting from DNA damage |
| 07/23/2003 | CN1431200A Compound of phycocyania of blue-green algae, its preparing method and usage |
| 07/23/2003 | CN1431019A Propolis capsule of superoxide dismutase |
| 07/23/2003 | CN1115156C Antisenescence Chinese medicine |
| 07/22/2003 | US6596750 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 07/22/2003 | US6596733 Nitric oxide scavengers, such as dithiocarbamate-containing compounds, are used to reduce side effects caused by therapeutical administration of nitric oxide sources |
| 07/22/2003 | US6596721 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 07/22/2003 | US6596718 7-Morpholin-4yl-benzothiazole amide derivatives |
| 07/21/2003 | CA2416791A1 A receptor-ligand pairing for immune response |
| 07/21/2003 | CA2368656A1 Receptor-ligand pairing for anti-inflammatory response |
| 07/17/2003 | WO2003057730A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | WO2003057707A1 2-o-( -d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 07/17/2003 | WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057141A2 Methods for improving the aesthetic appearance of skin |
| 07/17/2003 | WO2003030827A3 Compositions for and methods of treating and preventing sirs/sepsis |
| 07/17/2003 | WO2002009723A3 Ammonium salts of hemoglobin allosteric effectors, and uses thereof |
| 07/17/2003 | US20030133921 Enterobacteria live or dead as active materials can absorbing the toxic chemical in body intestinal tracts, and accelerate excretion from body; detoxification |
| 07/17/2003 | CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | CA2471657A1 Methods for improving the aesthetic appearance of skin |
| 07/17/2003 | CA2471504A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/16/2003 | EP1326894A2 Novel tumor-associated marker |
| 07/16/2003 | EP1326869A1 Pyrrole-condensed morphinoid derivatives |
| 07/16/2003 | EP1326834A2 2-substituted heterocyclic compounds |
| 07/16/2003 | EP1210353B1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 07/16/2003 | EP0814790B1 Administration of ketamine for detoxification |
| 07/16/2003 | CN1430511A Method of improving survival of patients |
| 07/16/2003 | CN1430510A Novel formulations of alpha 2,4-disulforphenyl-N-tert-butylnitrone |
| 07/16/2003 | CN1429556A Muscle strong agent and anti-inflammatory agent |
| 07/15/2003 | US6592860 Composition and applicator for topical substance delivery |
| 07/15/2003 | CA2059817C Polyamine thiols as radioprotective agents |
| 07/10/2003 | WO2003055913A2 Secreted protein |
| 07/10/2003 | WO2003055912A2 Secreted proteins |
| 07/10/2003 | US20030131363 Controlling the activation of genetic translation, cell proliferation, especially hematopoietic cells; drug screening for compounds which alter the activity of the kinase; thalassemias, sickle cell disease, unstable hemoglobins |
| 07/10/2003 | US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders |
| 07/10/2003 | US20030130260 Aryl fused azapolycyclic compounds |
| 07/10/2003 | US20030129150 Cosmetic preparations containing plant extracts |
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | EP1324809A1 Process for selectively extracting bioactive components |
| 07/09/2003 | EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition |
| 07/09/2003 | EP1324760A1 Creatine ester pronutrient compounds and formulations |
| 07/09/2003 | EP1066277B1 Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
| 07/09/2003 | EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/09/2003 | CN1429115A Adsorbent for endocrine disruptors and foods and drinks containing the same |
| 07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589948 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 07/08/2003 | US6589944 A method of cleaving glycation endproducts or cross-linked proteins in an organism in need thereof, wherein said method comprises administering an effective amount of a compound or pharmaceutically acceptable salt thereof to said organism for |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003053442A1 Tempamine compositions and methods of use |
| 07/03/2003 | WO2003053336A2 Methods for the treatment of peripheral neural and vascular ailments |
| 07/03/2003 | US20030125560 Treating an N-formyl paroxetine compound with a de-formylation agent selected from hydrochloric acid, acetic acid, formic acid, methane sulfonic acid, maleic acid, and tartaric acid forms a salt of paroxetine |
| 07/03/2003 | US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | CA2470603A1 Methods for the treatment of peripheral neural and vascular ailments |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2469047A1 Tempamine compositions and methods of use |
| 07/02/2003 | EP1323714A1 1,3-selenazole derivatives and their use as anticancer drugs or as agrochemicals |
| 07/02/2003 | EP1322760A2 G-protein coupled receptors |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP1322318A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 07/02/2003 | CN1426812A Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma |
| 07/02/2003 | CN1426800A Snake poison capsule for treating lung cancer and its preparation method |
| 07/01/2003 | US6586631 Acetoacetarylamide as solidified melt in form which can be used in industry and is easy to handle, which has water content between 3 and 15 percent by weight |
| 07/01/2003 | US6586476 Methods for the treatment of nephro-disorders using aminothiol compounds |
| 07/01/2003 | US6586474 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586448 Cholesteryl ester transfer protein inhibitors used as antilipemic agents for prophylaxis of cardiovascular disorders |
| 07/01/2003 | US6585973 Solid phase adjuvant methodology is used to synthesize a hapten-protein-polysaccharide conjugate vaccines to stimulate an anti- polysaccharide antibody response in infants who are otherwise unable to respond to polysaccharide alone |
| 06/26/2003 | WO2003051893A2 Improvements in pharmaceutical compositions |
| 06/26/2003 | WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS |
| 06/26/2003 | WO2003051807A2 Improvements in pharmaceutical compositions |
| 06/26/2003 | WO2003051805A2 Substituted phenyl naphthalenes as estrogenic agents |
| 06/26/2003 | WO2003051380A2 Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 06/26/2003 | WO2003051287A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 06/26/2003 | US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation |
| 06/26/2003 | US20030118577 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies |
| 06/26/2003 | US20030118536 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 06/26/2003 | US20030118507 Methods of using 46828, a human acyl-CoA synthetase |
| 06/26/2003 | CA2470060A1 Improvements in pharmaceutical compositions |
| 06/26/2003 | CA2469976A1 Improvements in pharmaceutical compositions |
| 06/26/2003 | CA2465888A1 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 06/25/2003 | EP1321516A2 Hydrogel matrix for cellular tissue storage |
| 06/25/2003 | EP1321152A1 Antidote for org 31540/SR 90107A |
| 06/25/2003 | EP1320532A1 Tetrapyrroles |
| 06/25/2003 | EP1320371A2 Charged phospholipid compositions and methods for their use |
| 06/25/2003 | EP1320365A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 06/25/2003 | EP1263470B1 METHOD FOR PRODUCING A COENZYME Q10 / $g(g)-CYCLODEXTRIN COMPLEX |
| 06/25/2003 | CN1426464A Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 06/24/2003 | US6583271 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 06/24/2003 | US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper |